Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Roivant Sciences (ROIV) Cost of Revenue (2020 - 2025)

Roivant Sciences' Cost of Revenue history spans 6 years, with the latest figure at $700000.0 for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 170.27% year-over-year to $700000.0; the TTM value through Dec 2025 reached $1.2 million, up 35.55%, while the annual FY2025 figure was $911000.0, 43.03% down from the prior year.
  • Cost of Revenue reached $700000.0 in Q4 2025 per ROIV's latest filing, up from $111000.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $6.4 million in Q3 2021 to a low of $111000.0 in Q3 2025.
  • Average Cost of Revenue over 5 years is $1.6 million, with a median of $700000.0 recorded in 2025.
  • Peak YoY movement for Cost of Revenue: skyrocketed 792.45% in 2021, then plummeted 94.95% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $1.4 million in 2021, then surged by 159.1% to $3.6 million in 2022, then crashed by 94.51% to $197000.0 in 2023, then skyrocketed by 31.47% to $259000.0 in 2024, then soared by 170.27% to $700000.0 in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Cost of Revenue are $700000.0 (Q4 2025), $111000.0 (Q3 2025), and $154000.0 (Q2 2025).